COVID-19 and the Brain: Impact on Nuclear Medicine in Neurology

Overview

Journal Eur J Nucl Med Mol Imaging

Specialties Biophysics
Nuclear Medicine
Radiology

Date 2020 Jul 24

PMID 32700058

Citations 12

Authors

Silvia Morbelli

Ozgul Ekmekcioglu

Henryk Barthel

Nathalie L Albert

Ronald Boellaard

Diego Cecchin

Eric Guedj

Adriaan A Lammertsma

Ian Law

Ivan Penuelas

Franck Semah

Tatjana Traub-Weidinger

Elsmarieke van de Giessen

Andrea Varrone

Valentina Garibotto

Affiliations

Soon will be listed here.

Citing Articles

Radiological markers of neurological manifestations of post-acute sequelae of SARS-CoV-2 infection: a mini-review.

Cull O, Al Qadi L, Stadler J, Martin M, El Helou A, Wagner J Front Neurol. 2023; 14:1233079.

PMID: 38073629 PMC: 10704137. DOI: 10.3389/fneur.2023.1233079.

Refueling the post COVID-19 brain: potential role of ketogenic medium chain triglyceride supplementation: an hypothesis.

Juby A, Cunnane S, Mager D Front Nutr. 2023; 10:1126534.

PMID: 37415915 PMC: 10320593. DOI: 10.3389/fnut.2023.1126534.

Cerebral Metabolic Rate of Glucose and Cognitive Tests in Long COVID Patients.

Miskowiak K, Bech J, Henriksen A, Johnsen S, Podlekareva D, Marner L Brain Sci. 2023; 13(1).

PMID: 36672005 PMC: 9856023. DOI: 10.3390/brainsci13010023.

The Legacy of the TTASAAN Report - Premature Conclusions and Forgotten Promises About SPECT Neuroimaging: A Review of Policy and Practice Part II.

Pavel D, Henderson T, DeBruin S, Cohen P Front Neurol. 2022; 13:851609.

PMID: 35655621 PMC: 9152128. DOI: 10.3389/fneur.2022.851609.

Temporal Changes in Brain Perfusion in a Patient with Myoclonus and Ataxia Syndrome Associated with COVID-19.

Osawa K, Sugiyama A, Uzawa A, Hirano S, Yamamoto T, Nezu M Intern Med. 2022; 61(7):1071-1076.

PMID: 35110499 PMC: 9038453. DOI: 10.2169/internalmedicine.9171-21.

References

Hainque E, Grabli D . Rapid worsening in Parkinson's disease may hide COVID-19 infection. Parkinsonism Relat Disord. 2020; 75:126-127. PMC: 7205634. DOI: 10.1016/j.parkreldis.2020.05.008. View

Pilotto A, Odolini S, Masciocchi S, Comelli A, Volonghi I, Gazzina S . Steroid-Responsive Encephalitis in Coronavirus Disease 2019. Ann Neurol. 2020; 88(2):423-427. PMC: 7276848. DOI: 10.1002/ana.25783. View

McDermott M, Newman A . Preserving Clinical Trial Integrity During the Coronavirus Pandemic. JAMA. 2020; 323(21):2135-2136. DOI: 10.1001/jama.2020.4689. View

Helmich R, Bloem B . The Impact of the COVID-19 Pandemic on Parkinson's Disease: Hidden Sorrows and Emerging Opportunities. J Parkinsons Dis. 2020; 10(2):351-354. PMC: 7242824. DOI: 10.3233/JPD-202038. View

Ait Wahmane S, Achbani A, Ouhaz Z, Elatiqi M, Belmouden A, Nejmeddine M . The Possible Protective Role of α-Synuclein Against Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Patients With Parkinson's Disease. Mov Disord. 2020; 35(8):1293-1294. PMC: 7300655. DOI: 10.1002/mds.28185. View

Cummings J, Lee G, Ritter A, Sabbagh M, Zhong K . Alzheimer's disease drug development pipeline: 2019. Alzheimers Dement (N Y). 2019; 5:272-293. PMC: 6617248. DOI: 10.1016/j.trci.2019.05.008. View

Kuroda N . Epilepsy and COVID-19: Associations and important considerations. Epilepsy Behav. 2020; 108:107122. PMC: 7174174. DOI: 10.1016/j.yebeh.2020.107122. View

Karimi-Galougahi M, Yousefi-Koma A, Bakhshayeshkaram M, Raad N, Haseli S . FDG PET/CT Scan Reveals Hypoactive Orbitofrontal Cortex in Anosmia of COVID-19. Acad Radiol. 2020; 27(7):1042-1043. PMC: 7196385. DOI: 10.1016/j.acra.2020.04.030. View

Morbelli S, Arbizu J, Booij J, Chen M, Chetelat G, Cross D . The need of standardization and of large clinical studies in an emerging indication of [F]FDG PET: the autoimmune encephalitis. Eur J Nucl Med Mol Imaging. 2016; 44(3):353-357. DOI: 10.1007/s00259-016-3589-9. View

10.

Fleming T, Labriola D, Wittes J . Conducting Clinical Research During the COVID-19 Pandemic: Protecting Scientific Integrity. JAMA. 2020; 324(1):33-34. DOI: 10.1001/jama.2020.9286. View

11.

Moldofsky H, Patcai J . Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011; 11:37. PMC: 3071317. DOI: 10.1186/1471-2377-11-37. View

12.

Li Y, Bai W, Hashikawa T . The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020; 92(6):552-555. PMC: 7228394. DOI: 10.1002/jmv.25728. View

13.

Paez D, Gnanasegaran G, Fanti S, Bomanji J, Hacker M, Sathekge M . COVID-19 pandemic: guidance for nuclear medicine departments. Eur J Nucl Med Mol Imaging. 2020; 47(7):1615-1619. PMC: 7159284. DOI: 10.1007/s00259-020-04825-8. View

14.

Guedj E, Million M, Dudouet P, Tissot-Dupont H, Bregeon F, Cammilleri S . F-FDG brain PET hypometabolism in post-SARS-CoV-2 infection: substrate for persistent/delayed disorders?. Eur J Nucl Med Mol Imaging. 2020; 48(2):592-595. PMC: 7391029. DOI: 10.1007/s00259-020-04973-x. View

15.

Nobili F, Arbizu J, Bouwman F, Drzezga A, Agosta F, Nestor P . European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus. Eur J Neurol. 2018; 25(10):1201-1217. DOI: 10.1111/ene.13728. View

16.

Bassetti M, Vena A, Giacobbe D . The novel Chinese coronavirus (2019-nCoV) infections: Challenges for fighting the storm. Eur J Clin Invest. 2020; 50(3):e13209. PMC: 7163647. DOI: 10.1111/eci.13209. View

17.

Leonardi M, Padovani A, McArthur J . Neurological manifestations associated with COVID-19: a review and a call for action. J Neurol. 2020; 267(6):1573-1576. PMC: 7238392. DOI: 10.1007/s00415-020-09896-z. View

18.

Meles S, Vadasz D, Renken R, Sittig-Wiegand E, Mayer G, Depboylu C . FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder. Mov Disord. 2017; 32(10):1482-1486. PMC: 5655750. DOI: 10.1002/mds.27094. View

19.

Jennings D, Siderowf A, Stern M, Seibyl J, Eberly S, Oakes D . Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter-Deficit Prodromal Cohort. JAMA Neurol. 2017; 74(8):933-940. PMC: 5710321. DOI: 10.1001/jamaneurol.2017.0985. View

20.

Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B . COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features. Radiology. 2020; 296(2):E119-E120. PMC: 7233386. DOI: 10.1148/radiol.2020201187. View